ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Balance Sheet
NASDAQ:ASBP • US7389202067
Current stock price
1.05 USD
-0.07 (-6.67%)
At close:
1.05 USD
0 (0%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.95M | N/A | 0.00 | 500.00K | N/A | |||
| Receivables | N/A | 36.50K | N/A | N/A | N/A | |||
| Inventories | 35.40K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 419.40K | 9.30K | 81.20K | 600.00K | N/A | |||
| Total Current Assets | 2.40M | 45.80K | 81.20K | 1.10M | N/A | |||
| Non-Current Assets | ||||||||
| Investments And Advances | N/A | 6.67M | 19.90M | 299.00M | N/A | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 100.00K | N/A | |||
| Total Non-Current Assets | 0.00 | 6.67M | 19.90M | 299.10M | N/A | |||
| TOTAL ASSETS | 2.40M | 6.71M | 19.98M | 300.20M | N/A | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 8.62M | 14.23M | 12.40K | 0.00 | N/A | |||
| Accrued Expenses | 266.90K | N/A | N/A | 0.00 | N/A | |||
| Accounts Payable | 1.06M | 1.03M | 152.00K | 200.00K | N/A | |||
| Other Current Liabilities | 3.91M | 358.90K | 238.90K | 100.00K | N/A | |||
| Total Current Liabilities | 13.86M | 15.62M | 403.30K | 300.00K | N/A | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Other Non-Current Liabilities | 9.90K | N/A | 0.00 | 10.80M | N/A | |||
| Total Non-Current Liabilities | 9.90K | 0.00 | 0.00 | 10.80M | N/A | |||
| TOTAL LIABILITIES | 13.87M | 15.62M | 403.30K | 11.10M | N/A | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -22.55M | -24.37M | -11.29M | -9.90M | N/A | |||
| Additional Paid In Capital | 11.08M | 8.80M | 10.96M | 0.00 | N/A | |||
| Common Shares | 5.00K | 6.67M | 19.90M | 299.00M | N/A | |||
| Shares Outstanding | 1.24M | 194.10K | 224.80K | 7.91M | N/A | |||
| Tangible Book Value per Share | -9.26 | -45.85 | 87.10 | 8.05 | N/A | |||
| Total Shareholders' Equity | -11.47M | -8.90M | 19.58M | 289.10M | N/A | |||
| TOTAL LIABILITIES AND EQUITY | 2.40M | 6.71M | 19.98M | 300.20M | N/A | |||
| Statistics | ||||||||
| Current Ratio | 0.17 | 0.00 | 0.20 | 3.67 | N/A | |||
| Return On Assets (ROA) | -1194.47% | -186.73% | 22.34% | 1.11% | N/A | |||
| Return On Equity (ROE) | N/A | N/A | 22.80% | 1.16% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21